Skip to content
Lina Olsson HiloProbe.jpg

Image -

Lina Olsson HiloProbe.jpg

go to media item
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:
.jpg
Size:
3936 x 2418, 1.72 MB
Download

Topics

Contacts

Tomas Ruuth

Tomas Ruuth

Press contact Head of PR & Communications PR & Communications 072-4024697 www.ubi.se

Related content

Lina Olsson, CEO of HiloProbe, which works in the cancer diagnostics field. The companys has developed ColoNode, a reagent kit for analyzing lymph nodes in colorectal cancer patients.

HiloProbe secures 3 SEK Million in funding for sales initiation

HiloProbe, based in Umeå, secures SEK 3 million in funding from existing owners for sales initiation. The capital injection aims to attract more investment and reach a break-even point. The company is close to a breakthrough with ColoNode, a reagent kit for analyzing lymph nodes in colorectal cancer patients.

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden